The Pharmaceutical Industry is faced with the challenge of implementing and managing innovation in an era of rapid technological advancement.

Pharmaceuticals is the sector where innovation has a dramatic impact on the health and wellness of millions of people and the bottom lines of companies that drive it forward.

Companies have come to realize that in order to increase R&D productivity, they need to dramatically improve their ability to harness knowledge and capabilities residing both within and beyond their organizational boundaries—through strategic alliances, partnerships, and AI-driven collaborations.

For most pharmaceutical companies, innovation is the central element of their corporate mission, now amplified by AI's transformative role from discovery to development.

With AI projected to drive 30% of new drug discoveries by 2025, cutting costs and accelerating personalized treatments, the industry recognizes the vital need for implementing advanced digital technologies, such as Big Data Analytics, Artificial Intelligence, and other digital tools, to thrive and stay closer to patient needs—a trend that has only accelerated into the AI-native era of 2026.

Join our Global Innovation in Pharmaceutical R&D Summit 2026: Strategic AI in Pharma R&D: From Discovery to Development Partnerships, and gain the latest innovative insights from leading pharmaceutical, biotechnology, and AI companies.